Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Menicon Co ( (JP:7780) ) has issued an announcement.
Menicon Co., Ltd. reported a slight increase in revenue for its Vision Care business in the first quarter of FY2025, despite a decline in operating profit due to supply constraints and upfront costs for a new plant in Malaysia. The company remains optimistic about meeting its full-year forecast, driven by domestic price revisions and expanded supply capacity. In the orthokeratology-related market, Menicon plans to introduce new products and marketing strategies to maintain its leading position in China and capture growth opportunities in other regions. The impact of U.S. tariffs is expected to be limited due to the small revenue share from North America. Menicon has also initiated a share buyback program, reflecting its belief in the undervaluation of its stock and commitment to enhancing shareholder returns.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
More about Menicon Co
Menicon Co., Ltd. operates in the vision care industry, primarily focusing on the production of contact lenses and related products. The company is known for its silicone-based daily disposable contact lenses and holds a strong market position in orthokeratology lenses, particularly in China.
YTD Price Performance: -11.69%
Average Trading Volume: 492,917
Technical Sentiment Signal: Sell
Current Market Cap: Yen92.05B
Find detailed analytics on 7780 stock on TipRanks’ Stock Analysis page.